Adial Pharmaceuticals Stock Forecast

ADIL's stock price has decreased by -50.68% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Adial Pharmaceuticals stock has a target of 8.00, which predicts an increase of 1,119.51% from the current stock price of 0.66.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$8.00	$8.00	$8.00	$8.00
Change	+1119.5%	+1119.5%	+1119.5%	+1119.5%

* Price targets were last updated on Nov 14, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Adial Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes Rodman & Renshaw	Rodman & Renshaw	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+1,119.51%	Nov 14, 2024
Kumaraguru Raja Brookline Capital	Brookline Capital	Strong Buy Reiterates $150	Strong Buy	Reiterates	$150	+22,765.85%	Jul 11, 2023
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 17, 2022
Kumaraguru Raja Brookline Capital	Brookline Capital	Strong Buy Initiates $300	Strong Buy	Initiates	$300	+45,631.71%	Oct 13, 2021
Theodore O'Neill Litchfield Hills	Litchfield Hills	Strong Buy Initiates $125	Strong Buy	Initiates	$125	+18,954.88%	Jun 29, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 71.68M

Revenue Next Year

n/a

EPS This Year

-1.78

from -2.72

EPS Next Year

-1.21

from -1.78

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	-	-	35.08M	71.68M
Revenue Growth	-	-	-	-	104.34%	-	-	-
EPS	-21.85	-26.12	-12.71	-3.60	-2.72	-1.78	-1.21	-0.94
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.28	-1.05	-0.58
Avg	-1.78	-1.21	-0.94
Low	-2.65	-1.34	-1.27

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.